Celcuity Inc. is a cancer-focused biotech company with one pipeline candidate, gedatolisib, showing promise in breast and prostate cancer. Gedatolisib is a differentiated PI3K inhibitor with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback